Biao Xie

Dr. Biao Xie

Chongqing Medical University, Chongqing, China
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2025 in Genes & Diseases
Verified
Journal Article
Open access
GLGuichuan Lai
Guichuan Lai
BXBiao Xie
Biao Xie
CZCong Zhang
Cong Zhang
XZXiaoni Zhong
Xiaoni Zhong
JDJielian Deng
Jielian Deng
AHAilong Huang
Ailong Huang
Immunosubtyping enables the segregation of immune responders from non-responders. However, numerous studies failed to focus on the integration of cellular heterogeneity and immunophenotyping in the prediction of hepatocellular carcinoma (HCC) patients' response to immune checkpoint inhibitors (ICIs). We categorized HCC patients into various immune subtypes based on feature scores linked to ICI response. Single-cell sequencing technology was to investigate the cellular heterogeneity of different immune subtypes and acquire significant ICI response-associated cells. Candidate drugs were identified using a blend of various drug databases and network approaches. HCC patients were divided into two distinct immune subtypes based on characterization scores of 151 immune-related gene sets. Patients in both subtypes showed varying overall survival, immunity levels, biological activities, and TP53 mutation rates. Subtype 1-related natural killer cells showed a positive correlation with immune-promoting scores but a negative correlation with immune-suppressing scores. Notably, docetaxel sensitivity in HCC patients rose as the levels of subtype 1-related natural killer cells increased. Our study demonstrated that immune subtypes have cellular heterogeneity in predicting response to ICIs. A combination of subtype 1-associated natural killer cells and docetaxel may offer new hope for ICI treatment in HCC.

3 April 2024 in Archives of Gerontology and Geriatrics
Verified
Journal Article
Closed access
CZCong Zhang
Cong Zhang
JDJielian Deng
Jielian Deng
KLKangjie Li
Kangjie Li
GLGuichuan Lai
Guichuan Lai
HLHui Liu
Hui Liu
BXBiao Xie
Biao Xie

13 July 2024 in EPMA Journal
Verified
Journal Article
Closed access
PDF file
CZCong Zhang
Cong Zhang
JYJinxiang Yang
Jinxiang Yang
SCSiyu Chen
Siyu Chen
LSLichang Sun
Lichang Sun
KLKangjie Li
Kangjie Li
BXBiao Xie
Biao Xie

16 December 2024 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
CZCong Zhang
Cong Zhang
DSDan Shi
Dan Shi
GLGuichuan Lai
Guichuan Lai
KLKangjie Li
Kangjie Li
YZYuan Zhang
Yuan Zhang
BXBiao Xie
Biao Xie

4 March 2024 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
KLKangjie Li
Kangjie Li
CZCong Zhang
Cong Zhang
JDJielian Deng
Jielian Deng
HZHaijiao Zeng
Haijiao Zeng
YZYuan Zhang
Yuan Zhang
BXBiao Xie
Biao Xie
Background: The causal association between gut microbiome and HIV infection remains to be elucidated. We conducted a two-sample mendelian randomization analysis to estimate the causality between gut microbiome and HIV infection. Methods: Publicly released genome-wide association studies summary data were collected to perform the mendelian analysis. The GWAS summary data of gut microbiome was retrieved from the MiBioGen consortium, which contains 18 340 samples from 24 cohorts. GWAS summary data of HIV infection was collected from the R5 release of FinnGen consortium, including 357 HIV infected cases and 218 435 controls. The SNPs were selected as instrumental variables according to our selection rules. And SNPs with a F-statistics less than ten were regarded as weak instrumental variables and excluded. Mendelian randomization analysis was conducted by five methods, including inverse variance weighted (IVW), MR-Egger, weighted median, weighted mode, and simple mode. The Cochran’s Q test and MR-Egger intercept test were performed to identify heterogeneity and pleiotropy. Leave-one-out analysis were used to test the sensitivity of the results. Results: Fifteen gut microbiota taxa showed causal effects on HIV infection according to the MR methods. Four taxa were observed to increase the risk of HIV infection, including Ruminococcaceae (OR: 2.468[1.043, 5.842], P: 0.039), RuminococcaceaeUCG005 (OR: 2.051[1.048, 4.011], P: 0.036), Subdoligranulum (OR: 3.957[1.762, 8.887], P < 0.001) and Victivallis (OR: 1.605[1.012, 2.547], P=0.044). Erysipelotrichaceae was protective factor of HIV infection (OR: 0.278[0.106, 0.731], P < 0.001) and Methanobrevibacter was also found to be associated with reduced risk of HIV infection (OR: 0.509[0.265, 0.980], P=0.043). Horizontal pleiotropy was found for Fusicatenibacter (P<0.05) according to the MR-Egger regression intercept analysis. No heterogeneity was detected. Conclusion: Our results demonstrate significant causal effects of gut microbiome on HIV infection. These findings facilitate future studies to develop better strategies for HIV prophylaxis through gut microbiome regulation. Further explorations are also warranted to dissect the mechanism of how gut microbiome affects HIV susceptibility.

19 June 2024 in Inflammation Research
Verified
Journal Article
Closed access
PDF file
YZYuan Zhang
Yuan Zhang
CZCong Zhang
Cong Zhang
JHJing He
Jing He
GLGuichuan Lai
Guichuan Lai
WLWenlong Li
Wenlong Li
BXBiao Xie
Biao Xie